Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.
Taverna JA, Hung CN, Williams M, Williams R, Chen M, Kamali S, Sambandam V, Hsiang-Ling Chiu C, Osmulski PA, Gaczynska ME, DeArmond DT, Gaspard C, Mancini M, Kusi M, Pandya AN, Song L, Jin L, Schiavini P, Chen CL.
Taverna JA, et al. Among authors: pandya an.
Lung Cancer. 2024 Apr;190:107533. doi: 10.1016/j.lungcan.2024.107533. Epub 2024 Mar 14.
Lung Cancer. 2024.
PMID: 38520909
Review.